The MSBase registry: Informing clinical practice
- PMID: 31120376
- DOI: 10.1177/1352458519848965
The MSBase registry: Informing clinical practice
Abstract
Over the last decade, clinical registries have significantly contributed to the pool of evidence that supports management decisions in patients with multiple sclerosis. Being the largest international registry of multiple sclerosis and neuroimmunological disorders, MSBase collects demographic, clinical and limited paraclinical information from patients managed in different regions and under various circumstances. In this review, we will provide an overview of its published output, with focus on the information with impact on the management of multiple sclerosis.
Keywords: MSBase; Observational data; registry; relapses; therapy.
Similar articles
-
MSBase: an international, online registry and platform for collaborative outcomes research in multiple sclerosis.Mult Scler. 2006 Dec;12(6):769-74. doi: 10.1177/1352458506070775. Mult Scler. 2006. PMID: 17263005
-
The Kurtzke EDSS rank stability increases 4 years after the onset of multiple sclerosis: results from the MSBase Registry.J Neurol Neurosurg Psychiatry. 2012 Mar;83(3):305-10. doi: 10.1136/jnnp-2011-301051. Epub 2011 Dec 28. J Neurol Neurosurg Psychiatry. 2012. PMID: 22205675
-
Towards personalized therapy for multiple sclerosis: prediction of individual treatment response.Brain. 2017 Sep 1;140(9):2426-2443. doi: 10.1093/brain/awx185. Brain. 2017. PMID: 29050389 Clinical Trial.
-
Analysis of current multiple sclerosis registries.Neurology. 2011 Jan 4;76(1 Suppl 1):S7-13. doi: 10.1212/WNL.0b013e31820502f6. Neurology. 2011. PMID: 21205683 Review.
-
Registry studies of long-term multiple sclerosis outcomes: description of key registries.Neurology. 2011 Jan 4;76(1 Suppl 1):S3-6. doi: 10.1212/WNL.0b013e3182050225. Neurology. 2011. PMID: 21205680 Review.
Cited by
-
Predictors of treatment switching in the Big Multiple Sclerosis Data Network.Front Neurol. 2023 Dec 22;14:1274194. doi: 10.3389/fneur.2023.1274194. eCollection 2023. Front Neurol. 2023. PMID: 38187157 Free PMC article.
-
Digital Dementia Registry Bavaria-digiDEM Bayern: study protocol for a multicentre, prospective, longitudinal register study.BMJ Open. 2021 Feb 8;11(2):e043473. doi: 10.1136/bmjopen-2020-043473. BMJ Open. 2021. PMID: 33558357 Free PMC article.
-
Natalizumab, Fingolimod and Dimethyl Fumarate Use and Pregnancy-Related Relapse and Disability in Women With Multiple Sclerosis.Neurology. 2021 Jun 15;96(24):e2989-e3002. doi: 10.1212/WNL.0000000000012084. Neurology. 2021. PMID: 33879599 Free PMC article.
-
Disease Reactivation After Cessation of Disease-Modifying Therapy in Patients With Relapsing-Remitting Multiple Sclerosis.Neurology. 2022 Oct 25;99(17):e1926-e1944. doi: 10.1212/WNL.0000000000201029. Epub 2022 Aug 17. Neurology. 2022. PMID: 35977837 Free PMC article.
-
Impact of methodological choices in comparative effectiveness studies: application in natalizumab versus fingolimod comparison among patients with multiple sclerosis.BMC Med Res Methodol. 2022 May 30;22(1):155. doi: 10.1186/s12874-022-01623-8. BMC Med Res Methodol. 2022. PMID: 35637426 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical